Deutsche Bank Ag\ Ginkgo Bioworks Holdings, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $786 - $3,257	-2,808 Reduced 3.71%	72,971 $24,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $9,178 - $14,460	8,659 Added 12.9%	75,779 $87,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $553 - $785	-439 Reduced 0.65%	67,120 $113,000
Q3 2023 Nov 09, 2023	BUY	$1.61 - $2.54 $80 - $127	50 Added 0.07%	67,559 $122,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $73,879 - $126,373	64,807 Added 2398.48%	67,509 $125,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $142,474 - $260,016	-118,729 Reduced 97.77%	2,702 $3,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $197,932 - $427,437	121,431 New	121,431 $205,000
Q2 2022 Aug 11, 2022	BUY	$2.2 - $4.2 $58,302 - $111,304	26,501 New	26,501 $63,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.